Internal Medicine, Rheumatology · Gainesville, GA
NPI
1053527275
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
700 S Enota Dr NE
Gainesville, GA, 30501
Phone (770) 531-3711
Groups this clinician bills Medicare through
Medicare paid, 2024
$972K
65,400 services
Medicare patients, 2024
385
Average age 72
Drug cost, 2024
$4.1M
5,127 prescriptions
Company payments, 2025
$2,417
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Huma Sohail was code J1602 (injection, golimumab, 1 mg, for intravenous use), 15,515 times for 39 patients. In total Huma Sohail billed 65,400 services in 74 codes, and Medicare paid $972K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 15,515 | 39 | $8.96 | $139K |
| J3262 Injection, tocilizumab, 1 mg | Office | 15,273 | 12 | $4.69 | $72K |
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,400 | 15 | $3.62 | $38K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,122 | 41 | $33.92 | $343K |
| J9312 Injection, rituximab, 10 mg | Office | 2,404 | 21 | $61.20 | $147K |
| J0897 Injection, denosumab, 1 mg | Office | 1,200 | 18 | $20.84 | $25K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 800 | 13 | $0.10 | $82.23 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 566 | 19 | $0.23 | $129 |
| 36415 Venipuncture Blood Collection | Office | 500 | 243 | $8.62 | $4,308 |
| 99214 Office E&M - Established | Office | 471 | 230 | $89.12 | $42K |
| 96413 Chemotherapy Administration | Office | 319 | 133 | $94.76 | $30K |
| 85025 Blood Count | Office | 213 | 160 | $7.57 | $1,613 |
| 80053 Clinical Chemistry | Office | 211 | 159 | $10.30 | $2,174 |
| 86140 Clinical Chemistry | Office | 204 | 157 | $5.06 | $1,031 |
| 85652 Clinical Chemistry | Office | 204 | 157 | $2.64 | $538 |
By year: 2022 $604K for 46,298 services; 2023 $693K for 42,497 services; 2024 $972K for 65,400 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 500 | 243 | $8.62 | $4,308 |
| 85025 Blood Count | 213 | 160 | $7.57 | $1,613 |
| 80053 Clinical Chemistry | 211 | 159 | $10.30 | $2,174 |
| 85652 Clinical Chemistry | 204 | 157 | $2.64 | $538 |
| 86140 Clinical Chemistry | 204 | 157 | $5.06 | $1,031 |
| 86480 Immunoassay | 24 | 24 | $60.74 | $1,458 |
| 83516 Immunoassay | 24 | 12 | $11.30 | $271 |
| 82550 Clinical Chemistry | 21 | 18 | $6.38 | $134 |
| 86200 Immunoassay | 12 | 12 | $12.69 | $152 |
| 86431 Immunoassay | 12 | 12 | $5.56 | $66.72 |
Medicare prescription drug claims, 2024
In 2024, the drug Huma Sohail prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 675 prescriptions and refills. In total Huma Sohail wrote 5,127 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 675 | 1,283 | 177 | $21K |
| Prednisone Generic | 529 | 711 | 172 | $2,497 |
| Methotrexate Methotrexate Sodium | 412 | 740 | 106 | $7,736 |
| Pregabalin Generic | 316 | 431 | 76 | $4,974 |
| Gabapentin Generic | 298 | 444 | 81 | $3,827 |
| Sulfasalazine Generic | 256 | 415 | 62 | $5,387 |
| Duloxetine Hcl Generic | 250 | 414 | 62 | $5,769 |
| Leflunomide Generic | 238 | 403 | 58 | $8,432 |
| Tramadol Hcl Generic | 159 | 175 | 35 | $829 |
| Humira(Cf) Pen Adalimumab | 106 | 110 | 12 | $762K |
| Otezla Apremilast | 98 | 104 | 14 | $524K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 92 | 100 | 25 | $1,653 |
| Tizanidine Hcl Generic | 88 | 116 | 28 | $1,929 |
| Alendronate Sodium Generic | 87 | 225 | 37 | $378 |
| Orencia Clickject Abatacept | 79 | 79 | 12 | $462K |
Brand drugs: - claims; generic drugs: 4,159 claims; opioid claims: 281.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Huma Sohail $2,417 ($2,417 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $714.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $714 |
| Novartis Pharmaceuticals Corporation NVS | 23 | $416 |
| Janssen Biotech, Inc. JNJ | 7 | $274 |
| Amgen Inc. AMGN | 14 | $243 |
| Genzyme Corporation SNY | 3 | $166 |
| UCB, Inc. UCB.BR | 7 | $142 |
| Pfizer Inc. PFE | 6 | $125 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $79.87 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $42.38 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $31.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.